| 書目名稱 | Experimental and Applied Immunotherapy | | 編輯 | Jeffrey Medin,Daniel Fowler | | 視頻video | http://file.papertrans.cn/319/318953/318953.mp4 | | 概述 | Reflects the inter-disciplinary nature of translational immunotherapy, and includes a description of the cellular players/molecular effectors and the distinct therapeutic strategies Ideal for laborato | | 圖書封面 |  | | 描述 | Immunotherapy is now recognized as an essential component of treatment for a widevariety of cancers. It is an interdisciplinary field that is critically dependent upon animproved understanding of a vast network of cross-regulatory cellular populations anda diversity of molecular effectors; it is a leading example of translational medicinewith a favorable concept-to-clinical-trial timeframe of just a few years. There are manyestablished immunotherapies already in existence, but there are exciting new cancer immunotherapies just on the horizon, which are likely to be more potent, less toxic and more cost effective than many therapies currently in use.Experimental and Applied Immunotherapy is a state-of-the-art text offering a roadmapleading to the creation of these future cancer-fighting immunotherapies. It includes essaysby leading researchers that cover a wide variety of topics including T cell and non-Tcell therapy, monoclonal antibody therapy, dendritic cell-based cancer vaccines, mesenchymalstromal cells, negative regulators in cancer immunology and immunotherapy,non-cellular aspects of cancer immunotherapy, the combining of cancer vaccines withconventional therapies, the combin | | 出版日期 | Book 2011 | | 關(guān)鍵詞 | Cancer; Immunotherapy; translational immunotherapy | | 版次 | 1 | | doi | https://doi.org/10.1007/978-1-60761-980-2 | | isbn_softcover | 978-1-62703-822-5 | | isbn_ebook | 978-1-60761-980-2 | | copyright | Springer Science+Business Media, LLC 2011 |
The information of publication is updating
|
|
|Archiver|手機(jī)版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-13 08:04
發(fā)表于 2025-3-21 16:30:23
